Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 31Breast Neoplasms 24Agnosia 11Pain 10Lung Neoplasms 10Leiomyoma 7Pancreatic Neoplasms 5Neoplasms 5Prostatic Neoplasms 4Rectal Neoplasms 3Neuroma 3Neuralgia 3Hot Flashes 3Colorectal Neoplasms 3Colonic Neoplasms 3Thyroid Nodule 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphedema 2Liver Neoplasms 2Kidney Neoplasms 2Ileus 2Hyperparathyroidism 2Goiter 2Digestive System Diseases 2Chronic Pain 2Breast Cancer Female 2Brain Neoplasms 2Adenomyosis 2Abdominal Cancer 2

Interventions

Morphine 1Dexmedetomidine 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Immune System Suppression × Bupivacaine × Clear all
NCT03024957 2021-01-14

Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity

Assiut University

Phase 1/2 Unknown
30 enrolled

Immune System Suppression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡